However, the combination of those markers with individual patients’ changes in IL1β and IL10 plasma concentrations as well as soluble TREM-1 levels and the responsiveness towards an endotoxin stimulus can provide valuable information for early SIRS prognosis. The gene discussed is IL10; the disease is systemic inflammatory response syndrome.